Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

被引:0
|
作者
Kotwal, Sradha S. [1 ,2 ]
Perkovic, Vlado [1 ,3 ]
机构
[1] Univ New South Wales, George Inst Global Hlth, Renal & Metab Div, Sydney, NSW, Australia
[2] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Sydney, NSW, Australia
来源
KIDNEY INTERNATIONAL REPORTS | 2025年 / 10卷 / 02期
关键词
KIDNEY; OUTCOMES; GLP-1;
D O I
10.1016/j.ekir.2024.11.1365
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287 / 290
页数:4
相关论文
共 50 条
  • [1] Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes
    Reppo, Ingrid
    Jakobson, Maili
    Volke, Vallo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [2] Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
    Perkovic, Vlado
    Tuttle, Katherine R.
    Rossing, Peter
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Bakris, George
    Baeres, Florian M. M.
    Idorn, Thomas
    Bosch-Traberg, Heidrun
    Lausvig, Nanna Leonora
    Pratley, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 109 - 121
  • [3] Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
    Stenberg, Erik
    Cao, Yang
    Ottosson, Johan
    Hedberg, Suzanne
    Naslund, Erik
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5812 - 5818
  • [5] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Williams, Thomas C.
    Stewart, Emma
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09): : 891 - 891
  • [6] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Marso, Steven P.
    Bain, Stephen C.
    Consoli, Agostino
    Eliaschewitz, Freddy G.
    Jodar, Esteban
    Leiter, Lawrence A.
    Lingvay, Ildiko
    Rosenstock, Julio
    Seufert, Jochen
    Warren, Mark L.
    Woo, Vincent
    Hansen, Oluf
    Holst, Anders G.
    Pettersson, Jonas
    Vilsboll, Tina
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1834 - 1844
  • [7] Semaglutide and Type 2 diabetes
    Malbos, Damien
    ACTUALITES PHARMACEUTIQUES, 2021, 60 (608): : 5 - 5
  • [8] Finerenone for Patients With CKD and Type 2 Diabetes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (08): : 713 - 713
  • [9] Effects of Semaglutide Treatment on Dietary Behavior in Japanese Patients with Type 2 Diabetes Mellitus
    Sato, Shiori T.
    Tosaki, Takahiro
    Kotorii, Aoi
    Kondo, Masaki
    Miura-Yura, Emiri
    Tsunekawa, Shin
    Himeno, Tatsuhito
    Kato, Yoshiro
    Nakamura, Jiro
    Kamiya, Hideki
    DIABETES, 2022, 71
  • [10] The Effects of Semaglutide on β-cell Function in Subjects with Type 2 Diabetes
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob Bonde
    Axelsen, Mads Buhl
    Flint, Anne
    DIABETES, 2016, 65 : A262 - A263